Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid
Authors
Keywords
-
Journal
LEUKEMIA RESEARCH
Volume 134, Issue -, Pages 107392
Publisher
Elsevier BV
Online
2023-09-20
DOI
10.1016/j.leukres.2023.107392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings
- (2022) Charanpreet Singh et al. ACTA ONCOLOGICA
- Long‐term real‐world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all‐trans retinoic acid without chemotherapy—a retrospective, single‐centre study
- (2022) Charanpreet Singh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
- (2020) Leonard Naymagon et al. LEUKEMIA RESEARCH
- A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)
- (2020) Jeffrey E. Lancet et al. Blood Advances
- Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone
- (2019) Wenyi Hou et al. BLOOD CELLS MOLECULES AND DISEASES
- Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid, arsenic trioxide, and gemtuzumab
- (2016) Yasmin Abaza et al. BLOOD
- Clinico-hematological profile and outcome of acute promyelocytic leukemia patients at a tertiary care center in North India
- (2015) J Dass et al. INDIAN JOURNAL OF CANCER
- Clinico-hematological profile and outcome of acute promyelocytic leukemia patients at a tertiary care center in North India
- (2015) J Dass et al. INDIAN JOURNAL OF CANCER
- Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
- (2015) Harry J Iland et al. Lancet Haematology
- Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study
- (2014) Kristjan Paulson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients
- (2014) R Rahmé et al. LEUKEMIA
- International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia
- (2013) Mirjana Mitrovic et al. MEDICAL ONCOLOGY
- Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia
- (2011) Hung Chang et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
- (2011) S Lehmann et al. LEUKEMIA
- Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release
- (2010) Huibo Li et al. THROMBOSIS AND HAEMOSTASIS
- Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells
- (2009) Jin Zhou et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now